In addition, inhibition of NOTCH signaling by exposure to the γ-secretase inhibitor Dibenzazepine (DBZ) resulted in a decrease of AP4 and c-MYC expression in SW620 CRC cells (Supplementary Fig. 9h). Here, TFAP4 is linked to colorectal carcinoma.